| 标题 |
Mocertatug rezetecan (GSK5733584), a B7-H4-targeted antibody-drug conjugate (ADC), in platinum-resistant ovarian cancer (PROC) and endometrial cancer (EC): First results from the global BEHOLD-1 study |
| 网址 | |
| DOI |
10.1016/j.ygyno.2026.02.027
doi
|
| 其它 |
期刊:Gynecologic Oncology 作者:Ana Oaknin; William McKean; Marloes van Dongen; Isabelle Ray-Coquard; Jung-Yun Lee; et al 出版日期:2026 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)